Canton Strategic Holdings CNTN
NASDAQ CNTN
$2.28 +0.03 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Canton Strategic Holdings (CNTN) Interest & Investment Income (2023 - 2026)

Canton Strategic Holdings' (CNTN) quarterly Interest & Investment Income came in at $318178.0 in Q1 2026, up 2268.1% YoY from $13436.0 in Q1 2025, and up 1203.05% on a QoQ basis from $24418.0 in Q4 2025.

Analysis

Canton Strategic Holdings (CNTN) Interest & Investment Income (2023 - 2026) Analysis & Trends

Canton Strategic Holdings (CNTN) has 4 years of Interest & Investment Income data on file, last reported at $318178.0 in Q1 2026.

  • Quarterly Interest & Investment Income rose 2268.1% year-over-year to $318178.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $346152.0 (up 106.72% YoY) and the FY2025 annual result came in at $41410.0, down 83.43% from the prior year.
  • Interest & Investment Income grew to $318178.0 in Q1 2026, from $24418.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $318178.0 in Q1 2026 to a low of $1388.0 in Q3 2025.
  • A 4-year average of $58625.2 and a median of $32248.0 in 2023 frame the typical range for Interest & Investment Income.
  • Annual changes were most pronounced in 2025 — Interest & Investment Income plunged 98.09% — and 2026, when it jumped 2268.1%.
  • Tracing CNTN's Interest & Investment Income over 4 years: stood at $57733.0 in 2023, then slumped by 52.07% to $27672.0 in 2024, then dropped by 11.76% to $24418.0 in 2025, then soared by 1203.05% to $318178.0 in 2026.
  • The last three Interest & Investment Income figures came in at $318178.0 (Q1 2026), $24418.0 (Q4 2025), and $1388.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 35.58 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 5.13 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 10.98 Mn
10 Canton Strategic Holdings 493.37 Mn 493.37 Mn - 311,848.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 311,848.00
Mar 31, 2026 318,178.00
Dec 31, 2025 24,418.00
Sep 30, 2025 1,388.00
Jun 30, 2025 2,168.00
Mar 31, 2025 13,436.00
Dec 31, 2024 27,672.00
Sep 30, 2024 72,728.00
Jun 30, 2024 53,614.00
Mar 31, 2024 95,894.00
Dec 31, 2023 57,733.00
Sep 30, 2023 28,451.00
Jun 30, 2023 34,199.00
Mar 31, 2023 32,248.00